ADRX-0134

N/A

Report date: 2025/04/28 15:44:37

Base Information

Drug NameADRX-0134
Drug Alias NameADRX-0134
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionSodium-dependent phosphate transport protein 2B inhibitors
TargetsSodium-dependent phosphate transport protein 2B
Therapy Area/IndicationsLung NeoplasmsOvarian NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdcentrx Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAdcentrx Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsOvarian Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A